Calliditas Therapeutics AB
NASDAQ:CALT

Watchlist Manager
Calliditas Therapeutics AB Logo
Calliditas Therapeutics AB
NASDAQ:CALT
Watchlist
Price: 40.0001 USD Market Closed
Market Cap: 1.1B USD

Wall Street
Price Targets

CALT Price Targets Summary
Calliditas Therapeutics AB

There are no price targets for CALT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Calliditas Therapeutics AB Competitors:
Price Targets
512
Grand Pharmaceutical Group Ltd
46% Upside
LUPIN
Lupin Ltd
10% Upside
002653
Haisco Pharmaceutical Group Co Ltd
75% Upside
EMCURE
Emcure Pharmaceuticals Ltd
19% Upside
600196
Shanghai Fosun Pharmaceutical Group Co Ltd
40% Upside
4016
Middle East Pharmaceutical Industries Company SJSC
12% Upside
HITI
High Tide Inc
93% Upside
ETON
Eton Pharmaceuticals Inc
85% Upside

Revenue
Forecast

Revenue Estimate
Calliditas Therapeutics AB

The compound annual growth rate of Calliditas Therapeutics AB's revenue for the next 3 years is 57%.

N/A
Past Growth
57%
Estimated Growth
Estimates Accuracy
4%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Calliditas Therapeutics AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss

Net Income
Forecast

Net Income Estimate
Calliditas Therapeutics AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CALT's stock price target?
Not Available

CALT doesn't have any price targets made by Wall Street professionals.

What is Calliditas Therapeutics AB's Revenue forecast?
Projected CAGR
57%

The compound annual growth rate of Calliditas Therapeutics AB's revenue for the next 3 years is 57%.

Back to Top